<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="splice">
            <roleset id="splice.01" name="" wordnet="3">
                <roles>
                    <role n="0" descr="gene or RNA&#x09;&#x09;&#x09;&#x09;&#x09;&#x09;&#x0A;" />
                    <role n="1" descr="specific component in gene/RNA to get spliced&#x09;&#x09;&#x09;// eg. extron, intron //&#x0A;" />
                    <role n="2" descr="gene product&#x09;&#x09;&#x09;&#x09;&#x09;&#x09;&#x09;// mRNA //&#x0A;" />
                    <role n="3" descr="location referring to organelle, cell or tissue&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>A caspase-2 minigene construct could be made to be alternatively spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="1">
                    <text>A caspase-2 minigene construct is made that can be spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="2">
                    <text>A caspase-2 minigene construct may be made that was spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="3">
                    <text>A caspase-2 minigene construct will be made that is alternatively spliced in transfected cells and nuclear extracts.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="4">
                    <text>A pre-mRNA containing mutations in SE2, however, is likely to be alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="5">
                    <text>A pre-mRNA containing mutations in SE2, however, will be alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="6">
                    <text>An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I can splice only 20% as efficiently as RNA 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="7">
                    <text>An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I will splice only 20% as efficiently as RNA 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="8">
                    <text>Consequently, exon 30 with the intron was spliced.</text>
                    <arg n="1">exon 30 with the intron</arg>
                </example>
                <example src="EGRAM" no="9">
                    <text>Exons outside this size range are observed to require additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">the mature mRNA</arg>
                </example>
                <example src="EGRAM" no="10">
                    <text>Exons outside this size range are observed to require additional exonic and/or intronic sequences to be spliced into the mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">the mature mRNA</arg>
                </example>
                <example src="EGRAM" no="11">
                    <text>Exons outside this size range require additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">the mature mRNA</arg>
                </example>
                <example src="EGRAM" no="12">
                    <text>However, a pre-mRNA containing mutations in SE2 has been alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="13">
                    <text>However, a pre-mRNA containing mutations in SE2 will be alternatively spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="14">
                    <text>The Supt4h gene is observed to be normally spliced from five exons encoded by chromosome 11.</text>
                    <arg n="0">The Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="15">
                    <text>The Supt4h gene was spliced normally from five exons encoded by chromosome 11.</text>
                    <arg n="0">The Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="16">
                    <text>The casp-2 minigene (C2) is able to be efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">The casp-2 minigene (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="17">
                    <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon having the ability to be efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon having the ability to be efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="19">
                    <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that can be spliced efficiently into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="20">
                    <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that is able to be efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="21">
                    <text>The pre-mRNAs from all of these genes may have been spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="EGRAM" no="22">
                    <text>The structure of different cDNA clones indicates that USF RNA has been shown to be spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="23">
                    <text>We also identified four transcriptional units that can be differentially spliced but contain no obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="24">
                    <text>We also identified four transcriptional units that have been shown to be differentially spliced but contained no obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="25">
                    <text>We also identified four transcriptional units that may have been differentially spliced but contained no obvious open reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="26">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate has been shown to be spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                    <arg n="0">the C2Gloi2 substrate</arg>
                    <arg n="1">the exon-skipping pathway</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>A caspase-2 minigene construct has the ability to be efficiently spliced transfected cells and nuclear extracts, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>A caspase-2 minigene construct is observed to be efficiently spliced transfected cells and nuclear extracts, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>Consequently, exons outside this size range can be spliced.</text>
                    <arg n="1">exons outside this size range</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>Consequently, exons outside this size range can be spliced.</text>
                    <arg n="1">exons outside this size range</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>Consequently, exons outside this size range can be spliced.</text>
                    <arg n="1">exons outside this size range</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>Consequently, exons outside this size range has been shown to be spliced.</text>
                    <arg n="1">exons outside this size range</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>Consequently, exons outside this size range has been shown to be spliced.</text>
                    <arg n="1">exons outside this size range</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>Consequently, exons outside this size range is able to be spliced.</text>
                    <arg n="1">exons outside this size range</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>Exons outside this size range required additional exonic and/or intronic sequences to be spliced into the mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>The casp-2 minigene (C2) could be made to be spliced in vitro.</text>
                    <arg n="0">The casp-2 minigene (C2)</arg>
                    <arg n="3">vitro</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>The casp-2 minigene (C2) has been made that can be alternatively spliced in vitro.</text>
                    <arg n="0">The casp-2 minigene (C2)</arg>
                    <arg n="3">vitro</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>The casp-2 minigene (C2) has been shown to be made that is alternatively spliced in in vitro.</text>
                    <arg n="0">The casp-2 minigene (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>The casp-2 minigene (C2) has been shown to be made that is spliced in vitro.</text>
                    <arg n="0">The casp-2 minigene (C2)</arg>
                    <arg n="3">vitro</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>The casp-2 minigene (C2) has been spliced efficiently vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">The casp-2 minigene (C2)</arg>
                    <arg n="3">vitro</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>The casp-2 minigene (C2) has the ability to be made to be alternatively spliced in vitro.</text>
                    <arg n="0">The casp-2 minigene (C2)</arg>
                    <arg n="3">vitro</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>The casp-2 minigene (C2) has the ability to be made to be spliced in vitro.</text>
                    <arg n="0">The casp-2 minigene (C2)</arg>
                    <arg n="3">vitro</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>The casp-2 minigene (C2) is able to be efficiently spliced vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">The casp-2 minigene (C2)</arg>
                    <arg n="3">vitro</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>The casp-2 minigene (C2) is made that can be spliced in in vitro.</text>
                    <arg n="0">The casp-2 minigene (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>The casp-2 minigene (C2) is made that can be spliced in in vitro.</text>
                    <arg n="0">The casp-2 minigene (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>The casp-2 minigene (C2) would be made that could be alternatively spliced in vitro.</text>
                    <arg n="0">The casp-2 minigene (C2)</arg>
                    <arg n="3">vitro</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>The mouse polymeric immunoglobulin receptor gene has exons outside this size range spliced efficiently into the mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">the mature mRNA</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>The mouse polymeric immunoglobulin receptor gene has exons outside this size range that has the ability to be spliced efficiently into the mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">the mature mRNA</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>The mouse polymeric immunoglobulin receptor gene has exons outside this size range that is able to be spliced efficiently into the mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">the mature mRNA</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>The structure of different cDNA clones indicates that A caspase-2 minigene construct has been differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>The structure of different cDNA clones indicates that A caspase-2 minigene construct is observed to be differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>The structure of different cDNA clones indicates that The pre-mRNAs from all of these genes will be differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>The structure of different cDNA clones indicates that four transcriptional units has been differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>The structure of different cDNA clones indicates that four transcriptional units may have been spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>The structure of different cDNA clones indicates that the C2Gloi2 substrate may have been differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
                    <arg n="0">the C2Gloi2 substrate</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>The structure of different cDNA clones indicates that the C2Gloi2 substrate was spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
                    <arg n="0">the C2Gloi2 substrate</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>We also identified A caspase-2 minigene construct that may have been spliced but contained no obvious open reading frame.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>We also identified A caspase-2 minigene construct that were spliced but contained no obvious open reading frame.</text>
                    <arg n="0">A caspase-2 minigene construct</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>We also identified The casp-2 minigene (C2) that are observed to be differentially spliced but contain no obvious open reading frame.</text>
                    <arg n="0">The casp-2 minigene (C2)</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>We also identified The casp-2 minigene (C2) that are observed to be differentially spliced but contain no obvious open reading frame.</text>
                    <arg n="0">The casp-2 minigene (C2)</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>We also identified The casp-2 minigene (C2) that are spliced but contain no obvious open reading frame.</text>
                    <arg n="0">The casp-2 minigene (C2)</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>We also identified The casp-2 minigene (C2) that could have been spliced but contained no obvious open reading frame.</text>
                    <arg n="0">The casp-2 minigene (C2)</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>We also identified The pre-mRNAs from all of these genes that were spliced but contained no obvious open reading frame.</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>We also identified USF RNA being able to be differentially spliced but containing no obvious open reading frame.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>We also identified USF RNA having been shown to be spliced but containing no obvious open reading frame.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>We also identified USF RNA that have been spliced but contained no obvious open reading frame.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>We also identified the C2Gloi2 substrate being able to be spliced but containing no obvious open reading frame.</text>
                    <arg n="0">the C2Gloi2 substrate</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>We also identified the C2Gloi2 substrate that could have been differentially spliced but contained no obvious open reading frame.</text>
                    <arg n="0">the C2Gloi2 substrate</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>We also identified the C2Gloi2 substrate that may have been spliced but contained no obvious open reading frame.</text>
                    <arg n="0">the C2Gloi2 substrate</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, The pre-mRNAs from all of these genes may have been spliced predominantly following little or no exon-skipping to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, The pre-mRNAs from all of these genes was spliced predominantly following little or no exon-skipping to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                    <arg n="0">The pre-mRNAs from all of these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>the C2Gloi2 substrate spliced with the exon-skipping pathway (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">the C2Gloi2 substrate</arg>
                    <arg n="1">the exon-skipping pathway</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>The Supt4h gene are spliced with five exons encoded by chromosome 11 (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>The Supt4h gene being able to be spliced with five exons (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The Supt4h gene</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>The Supt4h gene can be spliced with five exons (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The Supt4h gene</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>The Supt4h gene may have been spliced with five exons (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The Supt4h gene</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>The Supt4h gene shown to be spliced with five exons encoded by chromosome 11 (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>The Supt4h gene that have been shown to be spliced with five exons (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The Supt4h gene</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>The Supt4h gene that may have been spliced with five exons encoded by chromosome 11 (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>The Supt4h gene that will be spliced with five exons encoded by chromosome 11 (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>The Supt4h gene will be spliced with five exons encoded by chromosome 11 (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">The Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>The structure of different cDNA clones indicates that The Supt4h gene has been spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
                    <arg n="0">The Supt4h gene</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>The structure of different cDNA clones indicates that The Supt4h gene has the ability to be differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
                    <arg n="0">The Supt4h gene</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>The structure of different cDNA clones indicates that The Supt4h gene will be differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.</text>
                    <arg n="0">The Supt4h gene</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>We also identified The Supt4h gene having been shown to be differentially spliced but containing no obvious open reading frame.</text>
                    <arg n="0">The Supt4h gene</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>We also identified The Supt4h gene that were differentially spliced but contained no obvious open reading frame.</text>
                    <arg n="0">The Supt4h gene</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, The Supt4h gene can be spliced following five exons encoded by chromosome 11 to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                    <arg n="0">The Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, The Supt4h gene has been spliced following five exons encoded by chromosome 11 to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                    <arg n="0">The Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, The Supt4h gene has been spliced predominantly following five exons to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                    <arg n="0">The Supt4h gene</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, a pre-mRNA containing mutations in SE2 has been spliced following the nt 3605 3 splice site to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, a pre-mRNA containing mutations in SE2 was spliced predominantly following the nt 3605 3 splice site to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, a pre-mRNA containing mutations in SE2 will be spliced following the nt 3605 3 splice site to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, a pre-mRNA containing mutations in SE2 will be spliced predominantly following the nt 3605 3 splice site to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>a pre-mRNA containing mutations in SE2 being able to be spliced with the nt 3605 3 splice site (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>a pre-mRNA containing mutations in SE2 observed to be spliced with the nt 3605 3 splice site (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>a pre-mRNA containing mutations in SE2 shown to be spliced with the nt 3605 3 splice site (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="Virology" no="1">
                    <text>However, a pre-mRNA containing mutations in SE2 is spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
